New molecular and immunotherapeutic approaches in biliary cancer.
Name:
e000152.full.pdf
Size:
564.9Kb
Format:
PDF
Description:
Full text open access article
Affiliation
Department of Medical Oncology at the Nelune Cancer Centre, Prince of Wales Hospital, Sydney, New South WalesIssue Date
2017
Metadata
Show full item recordAbstract
Biliary tract carcinoma is a collective term for a group of rare gastrointestinal cancers. This overview outlines the key pathways and specialised therapeutics in biliary cancer and the emerging role of immunotherapy by highlighting the rationale and selected examples of studies in each area.Citation
New molecular and immunotherapeutic approaches in biliary cancer. 2017, 2 (Suppl 1):e000152 ESMO OpenJournal
ESMO OpenDOI
10.1136/esmoopen-2016-000152PubMed ID
28848675Type
ArticleLanguage
enISSN
2059-7029ae974a485f413a2113503eed53cd6c53
10.1136/esmoopen-2016-000152
Scopus Count
Collections
Related articles
- Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies.
- Authors: Marks EI, Yee NS
- Issue date: 2015 Nov 15
- Immunotherapeutic Approaches to Biliary Cancer.
- Authors: Shah UA, Nandikolla AG, Rajdev L
- Issue date: 2017 Jul
- Biomarker-Driven and Molecular Targeted Therapies for Hepatobiliary Cancers.
- Authors: Harris WP, Wong KM, Saha S, Dika IE, Abou-Alfa GK
- Issue date: 2018 Jun
- Immunotherapy of biliary tract cancer.
- Authors: Chai Y
- Issue date: 2016 Mar
- The case for immune-based approaches in biliary tract carcinoma.
- Authors: Duffy AG, Makarova-Rusher OV, Greten TF
- Issue date: 2016 Nov